Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist
Abstract
:1. Introduction
1.1. Purpose
1.2. Background
1.3. Elicitation of a History of Skin Lesions Resembling a Form of Erythema Migrans (EM)
2. Neurologic Features of Lyme Disease
3. Laboratory Tests as an Adjunct to Diagnosis of Lyme Disease Involving the Nervous System
4. Treatment of Neurologic Lyme Disease: Consideration of CNS-Penetrating Antibiotics
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Steere, A.C.; Malawista, S.E.; Snydman, D.R.; Shope, R.E.; Andiman, W.A.; Ross, M.R.; Steele, F.M. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 1977, 20, 7–17. [Google Scholar] [CrossRef] [PubMed]
- Steere, A.C.; Grodzicki, R.L.; Kornblatt, A.N.; Craft, J.E.; Barbour, A.G.; Burgdorfer, W.; Schmid, G.P.; Johnson, E.; Malawista, S.E. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 1983, 308, 733–740. [Google Scholar] [CrossRef]
- Benach, J.L.; Bosler, E.M.; Hanrahan, J.P.; Coleman, J.L.; Habicht, G.S.; Bast, T.F.; Cameron, D.J.; Ziegler, J.L.; Barbour, A.G.; Burgdorfer, W.; et al. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 1983, 308, 740–742. [Google Scholar] [CrossRef]
- Kugeler, K.J.; Schwartz, A.M.; Delorey, M.J.; Mead, P.S.; Hinckley, A.F. Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018. Emerg. Infect. Dis. 2021, 27, 616–619. [Google Scholar] [CrossRef] [PubMed]
- Wormser, G.P.; McKenna, D.; Jacobson, E.; Shanker, E.M.; Shaffer, K.D.; Scavarda, C.; Visintainer, P. Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment. Antimicrob. Agents Chemother. 2020, 65, e01895-20. [Google Scholar] [CrossRef] [PubMed]
- Berger, B.W. Erythema migrans. Clin. Dermatol. 1993, 11, 359–362. [Google Scholar] [CrossRef] [PubMed]
- Berger, B.W.; Johnson, R.C.; Kodner, C.; Coleman, L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J. Clin. Microbiol 1992, 30, 359–361. [Google Scholar] [CrossRef] [Green Version]
- Berger, B.W. Dermatologic manifestations of Lyme disease. Clin. Infect. Dis. 1989, 11, S1475–S1481. [Google Scholar] [CrossRef]
- Smith, R.P.; Schoen, R.T.; Rahn, D.W.; Sikand, V.K.; Nowakowski, J.; Parenti, D.L.; Holman, M.S.; Persing, D.H.; Steere, A.C. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med. 2002, 136, 421–428. [Google Scholar] [CrossRef]
- Schutzer, S.E.; Berger, B.W.; Krueger, J.G.; Eshoo, M.W.; Ecker, D.J.; Aucott, J.N. Atypical erythema migrans in patients with PCR-positive Lyme disease. Emerg. Infect. Dis. 2013, 19, 815–817. [Google Scholar] [CrossRef]
- CDC. Lyme Disease Rashes and Look-Alikes. Available online: https://www.cdc.gov/lyme/signs_symptoms/rashes.html (accessed on 21 March 2023).
- Dumic, I.; Vitorovic, D.; Spritzer, S.; Sviggum, E.; Patel, J.; Ramanan, P. Acute transverse myelitis-A rare clinical manifestation of Lyme neuroborreliosis. IDCases 2018, 15, e00479. [Google Scholar] [CrossRef] [PubMed]
- Garkowski, A.; Zajkowska, J.; Zajkowska, A.; Kułakowska, A.; Zajkowska, O.; Kubas, B.; Jurgilewicz, D.; Hładuński, M.; Łebkowska, U. Cerebrovascular Manifestations of Lyme Neuroborreliosis—A Systematic Review of Published Cases. Front. Neurol. 2017, 8, 146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Teles, C.; Gaspar, E.; Gonçalo, M.; Santos, L. Normocomplementemic urticarial vasculitis secondary to Lyme disease: A rare association with challenging treatment. J. R. Coll. Physicians Edinb. 2022, 14782715221144167. [Google Scholar] [CrossRef] [PubMed]
- Olson, J.C.; Esterly, N.B. Urticarial vasculitis and Lyme disease. J. Am. Acad. Dermatol. 1990, 22, 1114–1116. [Google Scholar] [CrossRef] [PubMed]
- Johnson, K.O.; Nelder, M.P.; Russell, C.; Li, Y.; Badiani, T.; Sander, B.; Sider, D.; Patel, S.N. Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005–2014. PLoS ONE 2018, 13, e0198509. [Google Scholar] [CrossRef]
- Wormser, G.P.; Masters, E.; Nowakowski, J.; McKenna, D.; Holmgren, D.; Ma, K.; Ihde, L.; Cavaliere, L.F.; Nadelman, R.B. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin. Infect. Dis. 2005, 41, 958–965. [Google Scholar] [CrossRef] [Green Version]
- Schutzer, S.E.; Body, B.A.; Boyle, J.; Branson, B.M.; Dattwyler, R.J.; Fikrig, E.; Gerald, N.J.; Gomes-Solecki, M.; Kintrup, M.; Ledizet, M.; et al. Direct Diagnostic Tests for Lyme Disease. Clin. Infect. Dis. 2019, 68, 1052–1057. [Google Scholar] [CrossRef]
- Branda, J.A.; Steere, A.C. Laboratory Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev. 2021, 34, e00018-19. [Google Scholar] [CrossRef]
- Coyle, P.K. Neurologic Lyme disease. Semin. Neurol. 1992, 12, 200–208. [Google Scholar] [CrossRef]
- Garcia-Monco, J.C.; Benach, J.L. Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections. Ann. Neurol. 2019, 85, 21–31. [Google Scholar] [CrossRef]
- Halperin, J.J. Central nervous system Lyme disease. Curr. Neurol. Neurosci. Rep. 2005, 5, 446–452. [Google Scholar] [CrossRef] [PubMed]
- Kaplan, R.F.; Jones-Woodward, L. Lyme encephalopathy: A neuropsychological perspective. Semin. Neurol. 1997, 17, 31–37. [Google Scholar] [CrossRef] [PubMed]
- Branda, J.A.; Body, B.A.; Boyle, J.; Branson, B.M.; Dattwyler, R.J.; Fikrig, E.; Gerald, N.J.; Gomes-Solecki, M.; Kintrup, M.; Ledizet, M.; et al. Advances in Serodiagnostic Testing for Lyme Disease Are at Hand. Clin. Infect. Dis. 2018, 66, 1133–1139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pegalajar-Jurado, A.; Schriefer, M.E.; Welch, R.J.; Couturier, M.R.; MacKenzie, T.; Clark, R.J.; Ashton, L.V.; Delorey, M.J.; Molins, C.R. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples. J. Clin. Microbiol. 2018, 56, e01943-17. [Google Scholar] [CrossRef] [Green Version]
- Nocton, J.J.; Dressler, F.; Rutledge, B.J.; Rys, P.N.; Persing, D.H.; Steere, A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 1994, 330, 229–234. [Google Scholar] [CrossRef]
- Lakos, A. CSF findings in Lyme meningitis. J. Infect. 1992, 25, 155–161. [Google Scholar] [CrossRef]
- Coyle, P.K.; Schutzer, S.E.; Belman, A.L.; Krupp, L.B.; Golightly, M.G. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: Detection of Borrelia-specific and-nonspecific complexes. Ann. Neurol. 1990, 28, 739–744. [Google Scholar] [CrossRef]
- Wormser, G.P.; Dattwyler, R.J.; Shapiro, E.D.; Halperin, J.J.; Steere, A.C.; Klempner, M.S.; Krause, P.J.; Bakken, J.S.; Strle, F.; Stanek, G.; et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 43, 1089–1134. [Google Scholar] [CrossRef]
- Lantos, P.M.; Rumbaugh, J.; Bockenstedt, L.K.; Falck-Ytter, Y.T.; Aguero-Rosenfeld, M.E.; Auwaerter, P.G.; Baldwin, K.; Bannuru, R.R.; Belani, K.K.; Bowie, W.R.; et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin. Infect. Dis. 2021, 72, e1–e48. [Google Scholar] [CrossRef]
- Steere, A.C.; Levin, R.E.; Molloy, P.J.; Kalish, R.A.; Abraham, J.H., 3rd; Liu, N.Y.; Schmid, C.H. Treatment of lyme arthritis. Arthritis Rheum. 1994, 37, 878–888. [Google Scholar] [CrossRef]
- Klempner, M.S.; Hu, L.T.; Evans, J.; Schmid, C.H.; Johnson, G.M.; Trevino, R.P.; Norton, D.; Levy, L.; Wall, D.; McCall, J.; et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 2001, 345, 85–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krupp, L.B.; Hyman, L.G.; Grimson, R.; Coyle, P.K.; Melville, P.; Ahnn, S.; Dattwyler, R.; Chandler, B. Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology 2003, 60, 1923–1930. [Google Scholar] [CrossRef] [PubMed]
- Fallon, B.A.; Keilp, J.G.; Corbera, K.M.; Petkova, E.; Britton, C.B.; Dwyer, E.; Slavov, I.; Cheng, J.; Dobkin, J.; Nelson, D.R.; et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008, 70, 992–1003. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dumic, I.; Severnini, E. "Ticking Bomb": The Impact of Climate Change on the Incidence of Lyme Disease. Can. J. Infect. Dis. Med. Microbiol. 2018, 2018, 5719081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Lyme Disease Stage | Rheumatologic Syndromes |
---|---|
Early Localized (Erythema migrans) |
|
Early Disseminated |
|
Late |
|
Demographics |
|
Symptoms |
|
Signs |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Govil, S.; Capitle, E.; Lacqua, A.; Khianey, R.; Coyle, P.K.; Schutzer, S.E. Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist. Pathogens 2023, 12, 576. https://doi.org/10.3390/pathogens12040576
Govil S, Capitle E, Lacqua A, Khianey R, Coyle PK, Schutzer SE. Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist. Pathogens. 2023; 12(4):576. https://doi.org/10.3390/pathogens12040576
Chicago/Turabian StyleGovil, Swati, Eugenio Capitle, Alexandra Lacqua, Reena Khianey, P.K. Coyle, and Steven E. Schutzer. 2023. "Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist" Pathogens 12, no. 4: 576. https://doi.org/10.3390/pathogens12040576